Why Are Lonmin Plc, Oxford BioMedica plc & Bango plc Among Today’s Biggest Gainers?

Should you buy or sell these 3 major gainers? Lonmin Plc (LON: LMI), Oxford BioMedica plc (LON: OXB) and Bango plc (LON: BGO)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shares in Lonmin (LSE: LMI) have soared by over 5% today after the mining company announced the appointment of a new CFO. Barrie van der Merwe will take over on 17 May and the market seems to have welcomed this prompt decision by the company following the resignation of Simon Scott.

Clearly, this is a time of major change for Lonmin as it seeks to implement an updated strategy in response to exceptionally difficult trading conditions. As part of this, it is restructuring its business and also seeking to cut costs; both of which are likely to have a positive impact on Lonmin’s bottom line over the medium to long term. And with Lonmin having the capital through which to effect its new plan following last year’s fundraising, its future seems to be brighter than it was just a handful of months ago.

This increased confidence plus a more stable commodity price environment has led to a rise in Lonmin’s share price of 99% since the turn of the year. This rapid increase could continue, although Lonmin remains a relatively high risk play and may only be of interest to less risk averse investors.

Also rising today are shares in Oxford BioMedica (LSE: OXB), with them being up over 11% despite no significant news flow having been released by the company today. In fact, the gene therapy specialist has not released an update since 7 March when it announced a new and expanded collaboration with Immune Design Corp. Since then its shares have fallen by around 6% but looking ahead, the company has clear potential to deliver profitability.

The challenge for investors, though, is that profitability may still be a long way off. And in the meantime Oxford BioMedica is in a cash burn phase which could require further fundraisings following its £8.1m placing in February. As such, and while Oxford BioMedica has a bright long term future in a very appealing space, it may only be worth a closer look for less risk averse investors.

Meanwhile, shares in mobile payments company Bango (LSE: BGO) have risen by 12% today despite a lack of news flow. Despite this, its shares have still fallen by 60% since the turn of the year even though Bango’s full-year results have showed that it is making progress. For example, it experienced significant growth in end user spend, with the company also doubling the rate of spending through the Bango payment platform. And with a stable cost base, it seems to be well-positioned to move towards profitability.

Of course, the market seems to be somewhat downbeat on Bango’s prospects judging by its recent share price fall. While today’s upward movement could indicate a change in sentiment, it may be prudent to await confirmation of this over the medium term before piling in.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A young Asian woman holding up her index finger
Investing Articles

Don’t miss this once-in-a-decade opportunity to profit from the stock market’s AI hype

Our writer considers a rare value opportunity that could emerge if AI hype leads to a siginficant stock market correction.…

Read more »

A senior man using hiking poles, on a hike on a coastal path along the coastline of Cornwall.
Investing Articles

£10,000 invested in easyJet shares on 1 April is now worth…

It's been a strange month for easyJet shares. But what exactly would have happened to a sum invested in the…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Down 29%, should I buy Palantir for my Stocks and Shares ISA?

Palantir Technologies has lost over a quarter of its value in the past few months. Does this make it a…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Selling for £1, are Lloyds shares still a bargain?

Lloyds shares sold for pennies for many years -- but now cost a pound. Our writer sees some strengths in…

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

How much could spending just £5 a day on UK shares earn in passive income?

Sticking to UK shares in well-known companies, our writer shows how £5 a day could be used to target over…

Read more »

Dominos delivery man on skateboard holding pizza boxes
Investing Articles

Think you’re too young for a SIPP? Think again!

Is a SIPP something best left to later in working life? Not at all, according to this writer -- and…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

These 5 FTSE 100 shares all offer dividend yields well above average!

Christopher Ruane gives the lowdown on a handful of FTSE 100 shares, all yielding considerably higher than the index, that…

Read more »

Investing Articles

How to turn a Stocks and Shares ISA into £10k of annual passive income

Mark Hartley outlines a simple method of achieving a stable passive income stream from a Stocks and Shares ISA without…

Read more »